Canale-Theakston Carin 4
4 · Cidara Therapeutics, Inc. · Filed Jan 25, 2021
Insider Transaction Report
Form 4
Canale-Theakston Carin
Director
Transactions
- Award
Stock Option (right to buy)
2021-01-22+35,000→ 35,000 totalExercise: $2.51Exp: 2031-01-21→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]1/3rd of the total number of shares subject to the award shall vest on January 22, 2022 and the remaining 2/3rds of the shares will vest in equal monthly installments over a two year period such that the option is fully vested on January 22, 2024.